Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013

IF 1.6 Q3 PHARMACOLOGY & PHARMACY Canadian Pharmacists Journal Pub Date : 2016-08-09 DOI:10.1177/1715163516662670
L. Dolovich, Giulia P. Consiglio, L. Mackeigan, L. Abrahamyan, P. Pechlivanoglou, V. Rac, N. Pojskic, Elizabeth A. Bojarski, J. Su, M. Krahn, S. Cadarette
{"title":"Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013","authors":"L. Dolovich, Giulia P. Consiglio, L. Mackeigan, L. Abrahamyan, P. Pechlivanoglou, V. Rac, N. Pojskic, Elizabeth A. Bojarski, J. Su, M. Krahn, S. Cadarette","doi":"10.1177/1715163516662670","DOIUrl":null,"url":null,"abstract":"Background: MedsCheck Annual (MCA) is an Ontario government-funded medication review service for individuals taking 3 or more prescription medications for chronic conditions. Methods: This cohort study analyzed linked administrative claims data from April 1, 2007, to March 31, 2013. Trends in MCA claims and recipient characteristics were examined. Results: A total of 1,498,440 Ontarians (55% seniors, 55% female) received an MCA. One-third (36%) had 2 or more MCAs within 6 years. Service provision increased over time, with a sharper increase from 2010 onward. Almost half of Ontario pharmacies made at least 1 MCA claim in the first month of the program. Hypertension, respiratory disease, diabetes, psychiatric conditions and arthritis were common comorbidities. Recipients older than 65 years were most commonly dispensed an antihypertensive and/or antihyperlipidemic drug in the prior year and received an average of 11 unique prescription medications. Thirty-eight percent of recipients visited an emergency department or were hospitalized in the year prior to their first MCA. Discussion: Over the first 6 years of the program, approximately 1 in 9 Ontarians received an MCA. There was rapid and widespread uptake of the service. Common chronic conditions were well represented among MCA recipients. Older MCA recipients had less emergency department use compared with population-based estimates. Conclusions: Medication reviews increased over time; however, the number of persons receiving the service more than once was low. Service delivery was generally consistent with program eligibility; however, there are some findings possibly consistent with delivery to less complex patients.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"149 1","pages":"293 - 302"},"PeriodicalIF":1.6000,"publicationDate":"2016-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163516662670","citationCount":"44","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Pharmacists Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1715163516662670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 44

Abstract

Background: MedsCheck Annual (MCA) is an Ontario government-funded medication review service for individuals taking 3 or more prescription medications for chronic conditions. Methods: This cohort study analyzed linked administrative claims data from April 1, 2007, to March 31, 2013. Trends in MCA claims and recipient characteristics were examined. Results: A total of 1,498,440 Ontarians (55% seniors, 55% female) received an MCA. One-third (36%) had 2 or more MCAs within 6 years. Service provision increased over time, with a sharper increase from 2010 onward. Almost half of Ontario pharmacies made at least 1 MCA claim in the first month of the program. Hypertension, respiratory disease, diabetes, psychiatric conditions and arthritis were common comorbidities. Recipients older than 65 years were most commonly dispensed an antihypertensive and/or antihyperlipidemic drug in the prior year and received an average of 11 unique prescription medications. Thirty-eight percent of recipients visited an emergency department or were hospitalized in the year prior to their first MCA. Discussion: Over the first 6 years of the program, approximately 1 in 9 Ontarians received an MCA. There was rapid and widespread uptake of the service. Common chronic conditions were well represented among MCA recipients. Older MCA recipients had less emergency department use compared with population-based estimates. Conclusions: Medication reviews increased over time; however, the number of persons receiving the service more than once was low. Service delivery was generally consistent with program eligibility; however, there are some findings possibly consistent with delivery to less complex patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2007年至2013年安大略省社区药房MedsCheck年度药物审查服务的使用情况
背景:MedsCheck年度(MCA)是安大略省政府资助的一项药物审查服务,针对服用3种或更多处方药治疗慢性疾病的个人。方法:本队列研究分析了2007年4月1日至2013年3月31日的相关行政索赔数据。研究了MCA索赔的趋势和接受者的特征。结果:共有1,498,440名安大略省人(55%为老年人,55%为女性)获得了MCA。三分之一(36%)的患者在6年内有2次或更多的mca。服务供应随着时间的推移而增加,自2010年以来增长幅度更大。几乎一半的安大略省药房在该计划的第一个月至少提出了一次MCA索赔。高血压、呼吸系统疾病、糖尿病、精神疾病和关节炎是常见的合并症。年龄大于65岁的受助人在前一年最常被分配抗高血压和/或抗高血脂药物,平均接受11种独特的处方药。38%的受助人在第一次MCA前一年曾去过急诊科或住院。讨论:在该计划的前6年里,大约每9个安大略省人中就有1个获得了MCA。这项服务得到了迅速而广泛的接受。常见的慢性疾病在MCA接受者中有很好的代表性。与基于人口的估计相比,老年MCA接受者使用急诊室的次数较少。结论:药物回顾随着时间的推移而增加;然而,接受一次以上服务的人数很少。提供的服务大体上符合项目资格;然而,有一些发现可能与对不太复杂的患者的治疗一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Canadian Pharmacists Journal
Canadian Pharmacists Journal PHARMACOLOGY & PHARMACY-
CiteScore
2.50
自引率
26.70%
发文量
43
期刊介绍: Established in 1868, the Canadian Pharmacists Journal is the oldest continuously published periodical in Canada. Our mission is to enhance patient care through advancement of pharmacy practice, with continuing professional development, peer-reviewed research, and advocacy. Our vision is to become the foremost journal for pharmacy practice and research.
期刊最新文献
The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study. Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectives. Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia. Enabling pharmacist prescribing: Lessons learned in Nova Scotia using behaviour change theory. British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1